Richard Katzman
Associate, Stockholm
Richard Katzman is a Stockholm-based associate working with Roschier’s Public M&A, Corporate Advisory and Equity Capital Markets practices. He joined Roschier in 2019.
Richard Katzman’s experience includes advising:
- Navamedic in the recommended cash offer to acquire Sensidose;
- KKR’s life science platform Gamma Biosciences in the USD 215 million sale of Astrea Bioseparations to Biotage;
- Aareon AG in its purchase of shares in Momentum Software Group;
- Cibus Nordic Real Estate in connection with a directed share issue through an accelerated book-building procedure;
- Cibus Nordic Real Estate in its acquisition of a Finnish real estate portfolio and directed share issue to AB Sagax;
- Cibus Nordic Real Estate in connection with a directed share issue through an accelerated book-building procedure;
- Synsam and CVC in the IPO and listing of Synsam’s shares on Nasdaq Stockholm;
- Castellum in the SEK 26.9 billion public offer for Kungsleden;
- Cibus Nordic Real Estate in connection with a directed share issue through an accelerated book-building procedure;
- EQT IX and Roar BidCo in their SEK 23.6 billion public offer for Recipharm;
- Danske Bank, Handelsbanken and Nordea in the fully guaranteed SEK 1.7 billion rights issue in Gränges AB;
- Cibus Nordic Real Estate AB (publ) in the SEK 1.9 billion acquisition of 111 properties from Coop and SEK 0.9 billion accelerated book building;
- Filtronic PLC (listed on AIM operated by the London Stock Exchange) in the sale of its telecoms antenna business to Microdata Telecom Innovation;
- Searchlight Capital Partners in the acquisition of shares to obtain more than 90% ownership of Opus Group.
Roschier (2019-)
Member of the Swedish Bar Association
Uppsala University, LL.M. (2019)
English, Swedish